Biohaven annual shares outstanding
2022
2023
2024
2025
Biohaven Shares Outstanding History (BHVN)
Biohaven reported 132.8M shares outstanding at the end of fiscal 2025.
View full Biohaven company overviewBiohaven annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 132.8M | 31.6M | +31.17% |
| 2024 | 2024-12-31 | 101.2M | 20.1M | +24.79% |
| 2023 | 2023-12-31 | 81.1M | 12.9M | +18.95% |
| 2022 | 2022-12-31 | 68.2M | — | — |
Biohaven quarterly shares outstanding
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 151.0M | 45.2M | +42.76% |
| Q1 2026 | 2026-03-31 | 150.5M | 48.4M | +47.41% |
| Q4 2025 | 2025-12-31 | 132.8M | 31.6M | +31.17% |
| Q3 2025 | 2025-09-30 | 105.8M | 10.9M | +11.49% |
| Q2 2025 | 2025-06-30 | 105.8M | 13.4M | +14.55% |
| Q1 2025 | 2025-03-31 | 102.1M | 20.3M | +24.81% |
| Q4 2024 | 2024-12-31 | 101.2M | 20.1M | +24.79% |
| Q3 2024 | 2024-09-30 | 94.9M | 26.5M | +38.81% |
| Q2 2024 | 2024-06-30 | 92.3M | 24.0M | +35.17% |
| Q1 2024 | 2024-03-31 | 81.8M | 13.6M | +19.93% |
| Q4 2023 | 2023-12-31 | 81.1M | 12.9M | +18.95% |
| Q3 2023 | 2023-09-30 | 68.4M | 68.4M | +68364043.00% |
| Q2 2023 | 2023-06-30 | 68.3M | — | — |
| Q1 2023 | 2023-03-31 | 68.2M | — | — |
| Q4 2022 | 2022-12-31 | 68.2M | — | — |
| Q3 2022 | 2022-09-30 | 100 | — | — |
Biohaven shares outstanding trends
Between the periods ended 2022-12-31 and 2025-12-31, Biohaven's shares outstanding moved from 68.2M to 132.8M, a change of 64.6M. The latest reported quarter, Q2 2026, shows 151.0M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biohaven source filings ↗Community posts
FDA accepts Biohaven's resubmitted application for spinocerebellar ataxia drug
Biohaven ($BHVN) said the FDA accepted its resubmitted application for Vyglxia, the proposed brand for troriluzole, to treat spinocerebellar ataxia. The submission includes additional supportive analyses and was deemed a complete response t ...
